UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
x
Form 10-K
o
Form 20-F
o
Form 11-K
o
Form 10-Q
o
Form N-SAR
o
Form N-CSR
For
Period
Ended:
December 31, 2016
x
Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q
¨
Transition Report on Form 10-K
¨
Transition Report on Form N-SAR
¨
For
the
Transition
Period
Ended:
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
Medical Imaging Corp.
Full Name of Registrant
N/A
Former Name if Applicable
848 N. Rainbow Blvd #2494
Address of Principal Executive Office
(Street and Number)
Las Vegas, Nevada 89107
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
x
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
|
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below
in
reasonable detail
why
Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR,
or
the
transition report
or
portion thereof, could
not
be
filed within
the
prescribed
time
period.
The Company’s auditors require additional time to complete their work on the 10-K for the period ended December 31, 2016, which renders the timely filing of the Form 10-K impracticable without undue hardship and expense to the Auditor.
PART IV — OTHER INFORMATION
(1)
Name and
telephone number
of
person
to
contact
in
regard
to
this
notification
|
Mitchell Geisler
|
(877)
|
|
331-3444
|
|
(Name)
|
(Area Code)
|
|
(Telephone Number)
|
(2)
Have all
other periodic reports required under Section
13 or
15(d)
of
the
Securities Exchange
Act
of
1934
or
Section
30
of
the
Investment
Company
Act
of
1940
during
the
preceding
12
months
or
for
such
shorter
period
that
the
registrant
was
required
to
file such
report(s)
been
filed
?
If
answer
is
no,
identify
report(s). Yes
x
No
o
(3)
Is it
anticipated
that any
significant change
in
results
of
operations
from the
corresponding period
for the last
fiscal
year will
be
reflected
by
the
earnings statements
to be
included
in
the
subject report
or
portion thereof
Yes
o
No
x
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
MEDICAL IMAGING CORP
.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date
March 31, 2017
By:
/s/ Mitchel Geisler
Mitchell Geisler, Chief Executive Officer
GENERAL INSTRUCTIONS
1.
This
form
is
required
by
Rule
12b-25
(17
CFR
240.12b-25)
of
the
General
Rules
and
Regulations
under
the
Securities
Exchange
Act
of
1934.
2.
One
signed
original
and
four
conformed
copies
of
this
form
and
amendments
thereto
must
be
completed
and
filed
with
the
Securities
and
Exchange
Commission,
Washington,
D.C.
20549,
in
accordance
with
Rule
0-3
of
the
General
Rules
and
Regulations under
the Act. The
information contained
in or
filed
with the form will
be
made
a
matter
of
public
record
in
the
Commission
files.
3.
A
manually
signed
copy
of
the
form
and
amendments
thereto
shall
be
filed
with
each
national
securities
exchange
on
which
any
class
of
securities
of
the
registrant
is
registered.
4.
Amendments
to
the
notifications
must also
be
filed
on
Form
12b-25
but need not
restate information
that has
been
correctly furnished.
The form
shall
be
clearly identified
as an
amended
notification.
5.
Electronic
Filers:
This
form
shall
not
be
used
by
electronic
filers
unable
to
timely
file
a
report
solely
due
to
electronic
difficulties. Filers unable
to
submit reports within
the time
period prescribed
due
to
difficulties
in
electronic
filing
should comply
with
either
Rule 201
or
Rule 202
of
Regulation
S-T
(§232.201
or
§232.202
of
this
chapter)
or
apply
for
an
adjustment
in
filing
date
pursuant
to
Rule
13(b)
of
Regulation
S-T
(§232.13(b)
of
this
chapter).
6.
Interactive
data
submissions
.
This
form
shall
not
be
used
by
electronic
filers
with
respect
to
the
submission
or
posting
of an
Interactive
Data
File
(§232.11
of
this
chapter).
Electronic
filers
unable
to
submit
or
post
an
Interactive
Data
File
within the time period prescribed should comply with either Rule 201 or 202 of Regulation S-T (§232.201 and §232.202 of this chapter).
|
Mitchell Geisler
|
(877)
|
|
331-3444
|
|
(Name)
|
(Area Code)
|
|
(Telephone Number)
|
(2)
Have all
other periodic reports required under Section
13 or
15(d)
of
the
Securities Exchange
Act
of
1934
or
Section
30
of
the
Investment
Company
Act
of
1940
during
the
preceding
12
months
or
for
such
shorter
period
that
the
registrant
was
required
to
file such
report(s)
been
filed
?
If
answer
is
no,
identify
report(s). Yes
x
No
o
(3)
Is it
anticipated
that any
significant change
in
results
of
operations
from the
corresponding period
for the last
fiscal
year will
be
reflected
by
the
earnings statements
to be
included
in
the
subject report
or
portion thereof
Yes
o
No
x
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
MEDICAL IMAGING CORP
.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date
March 31, 2017
By:
/s/ Mitchel Geisler
Mitchell Geisler, Chief Executive Officer
GENERAL INSTRUCTIONS
1.
This
form
is
required
by
Rule
12b-25
(17
CFR
240.12b-25)
of
the
General
Rules
and
Regulations
under
the
Securities
Exchange
Act
of
1934.
2.
One
signed
original
and
four
conformed
copies
of
this
form
and
amendments
thereto
must
be
completed
and
filed
with
the
Securities
and
Exchange
Commission,
Washington,
D.C.
20549,
in
accordance
with
Rule
0-3
of
the
General
Rules
and
Regulations under
the Act. The
information contained
in or
filed
with the form will
be
made
a
matter
of
public
record
in
the
Commission
files.
3.
A
manually
signed
copy
of
the
form
and
amendments
thereto
shall
be
filed
with
each
national
securities
exchange
on
which
any
class
of
securities
of
the
registrant
is
registered.
4.
Amendments
to
the
notifications
must also
be
filed
on
Form
12b-25
but need not
restate information
that has
been
correctly furnished.
The form
shall
be
clearly identified
as an
amended
notification.
5.
Electronic
Filers:
This
form
shall
not
be
used
by
electronic
filers
unable
to
timely
file
a
report
solely
due
to
electronic
difficulties. Filers unable
to
submit reports within
the time
period prescribed
due
to
difficulties
in
electronic
filing
should comply
with
either
Rule 201
or
Rule 202
of
Regulation
S-T
(§232.201
or
§232.202
of
this
chapter)
or
apply
for
an
adjustment
in
filing
date
pursuant
to
Rule
13(b)
of
Regulation
S-T
(§232.13(b)
of
this
chapter).
6.
Interactive
data
submissions
.
This
form
shall
not
be
used
by
electronic
filers
with
respect
to
the
submission
or
posting
of an
Interactive
Data
File
(§232.11
of
this
chapter).
Electronic
filers
unable
to
submit
or
post
an
Interactive
Data
File
within the time period prescribed should comply with either Rule 201 or 202 of Regulation S-T (§232.201 and §232.202 of this chapter).
